Thomas M. Moriarty is CLO & VP at CVS HEALTH Corp (CVS). They have made 12 open-market trades across 3 companies since 2007, most recently 2026-07-27.
CIK 0001412221
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $2.0M since 2026, against 11 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CVS | 315,273 | $25.2M |
| ACI | 308,946 | $4.2M |
| MHS | 77,137 | — |
| Total | $29.5M |
Shares reported on the most recent Form 4, priced at the 2026-07-28 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ACI | BUY | 2026-07-27 | 2026-07-28 | $11.51 | $2.0M | +0.5% | +2.3% | +17.1% |
| CVS | SELL | 2022-12-15 | 2022-12-16 | $98.36 | $27.0M | -2.0% | -6.3% | -20.5% |
| CVS | SELL | 2022-06-28 | 2022-06-30 | $95.00 | $13.2M | +0.7% | +3.5% | +5.8% |
| CVS | SELL | 2022-03-15 | 2022-03-17 | $105.00 | $5.4M | -3.5% | -4.7% | -15.7% |
| CVS | SELL | 2021-05-10 | 2021-05-12 | $86.00 | $9.4M | +7.3% | +2.2% | -0.4% |
| CVS | SELL | 2021-04-21 | 2021-04-23 | $77.00 | $8.0M | +9.0% | +17.7% | +8.4% |
| CVS | SELL | 2021-03-29 | 2021-03-30 | $76.15 | $9.6M | -2.0% | +0.5% | +10.7% |
| CVS | SELL | 2021-03-19 | 2021-03-23 | $74.15 | $7.3M | +4.0% | +5.6% | +16.5% |
| CVS | SELL | 2017-10-02 | 2017-10-03 | $81.17 | $3.3M | -10.3% | -14.2% | -9.1% |
| CVS | SELL | 2017-10-02 | 2017-10-03 | $81.17 | $1.7M | -10.3% | -14.2% | -9.1% |
| CVS | SELL | 2017-09-11 | 2017-09-12 | $79.61 | $14.4M | -3.2% | -10.4% | -11.2% |
| MHS | SELL · 10b5-1 | 2011-07-21 | 2011-07-22 | $65.31 | $2.2M | N/A | N/A | N/A |
| MHS | SELL · 10b5-1 | 2011-02-23 | 2011-02-24 | $61.14 | $489K | N/A | N/A | N/A |
| MHS | SELL · 10b5-1 | 2010-12-01 | 2010-12-02 | $61.75 | $298K | N/A | N/A | N/A |
| MHS | SELL · 10b5-1 | 2010-11-22 | 2010-11-23 | $61.00 | $2.1M | N/A | N/A | N/A |
| MHS | SELL · 10b5-1 | 2010-11-05 | 2010-11-08 | $59.25 | $2.8M | N/A | N/A | N/A |
| MHS | SELL · 10b5-1 | 2008-03-10 | 2008-03-12 | $42.50 | $345K | N/A | N/A | N/A |
| MHS | SELL | 2007-11-30 | 2007-12-03 | $101.39 | $598K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.